UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 626

Sortiert nach

The Natural History of Nonalcoholic Fatty Liver Disease—An Evolving View

Clinics in liver disease, 2018-02, Vol.22 (1), p.11-21

2018

Volltextzugriff (PDF)

Effect of Alcohol Consumption on Survival in Nonalcoholic Fatty Liver Disease: A National Prospective Cohort Study

Hepatology (Baltimore, Md.), 2019-08, Vol.70 (2), p.511-521

2019

Volltextzugriff (PDF)

Sarcopenia in Alcoholic Liver Disease: Clinical and Molecular Advances

Alcoholism, clinical and experimental research, 2017-08, Vol.41 (8), p.1419-1431

2017

Volltextzugriff (PDF)

Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: Findings and recommendations from an American Association for the Study of Liver Diseases–U.S. Food and Drug Administration Joint Workshop

Hepatology (Baltimore, Md.), 2015-04, Vol.61 (4), p.1392-1405

2015

Volltextzugriff (PDF)

Double-blind Randomized Placebo-controlled Clinical Trial of Omega 3 Fatty Acids for the Treatment of Diabetic Patients With Nonalcoholic Steatohepatitis

Journal of clinical gastroenterology, 2015-02, Vol.49 (2), p.137-144

2015

Volltextzugriff (PDF)

Nonalcoholic Steatohepatitis Decompensation and Portal Pressures

Clinical gastroenterology and hepatology, 2023-09, Vol.21 (10), p.2704-2704

2023

Volltextzugriff (PDF)

Pathophysiology of Nonalcoholic Steatohepatitis

Journal of clinical gastroenterology, 2006-03, Vol.40 Suppl 1, p.S17-S29

McCullough, Arthur J

2006

Volltextzugriff (PDF)

Natural History of Nonalcoholic Fatty Liver Disease

Digestive Diseases and Sciences, 2016-05, Vol.61 (5), p.1226-1233

2016

Volltextzugriff (PDF)

Accuracy of ultrasonographic fatty liver index using point-of-care ultrasound in stratifying non-alcoholic fatty liver disease patients

European journal of gastroenterology & hepatology, 2023-06, Vol.35 (6), p.654

2023

Volltextzugriff (PDF)

Insulin resistance : A metabolic pathway to chronic liver disease

Hepatology (Baltimore, Md.), 2005-11, Vol.42 (5), p.987-1000

2005

Volltextzugriff (PDF)

Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study

Journal of hepatology, 2009-12, Vol.51 (6), p.1061-1067

2009

Volltextzugriff (PDF)

Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis

JAMA : the journal of the American Medical Association, 2021-11, Vol.326 (20), p.2031

2021

Volltextzugriff (PDF)

Late evening snack: Exploiting a period of anabolic opportunity in cirrhosis

Journal of gastroenterology and hepatology, 2012-03, Vol.27 (3), p.430-441

2012

Volltextzugriff (PDF)

Epidemiology of the metabolic syndrome in the USA

Journal of digestive diseases, 2011-10, Vol.12 (5), p.333-340

McCULLOUGH, Arthur J

2011

Volltextzugriff (PDF)

The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease

Clinics in liver disease, 2004-08, Vol.8 (3), p.521-533

McCullough, Arthur J.

2004

Volltextzugriff (PDF)

Accuracy of steatosis and fibrosis NAFLD scores in relation to vibration controlled transient elastography: An NHANES analysis

Clinics and research in hepatology and gastroenterology, 2022-08, Vol.46 (7), p.101997-101997, Article 101997

2022

Volltextzugriff (PDF)

Cytokeratin-18 Fragment Levels as Noninvasive Biomarkers for Nonalcoholic Steatohepatitis: A Multicenter Validation Study

Hepatology (Baltimore, Md.), 2009-10, Vol.50 (4), p.1072-1078

2009

Volltextzugriff (PDF)

Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: Present and future

Hepatology (Baltimore, Md.), 2007-08, Vol.46 (2), p.582-589

2007

Volltextzugriff (PDF)

Plasma metabolomic profile in nonalcoholic fatty liver disease

Metabolism, clinical and experimental, 2011-03, Vol.60 (3), p.404-413

2011

Volltextzugriff (PDF)

Role of ceramides in nonalcoholic fatty liver disease

Trends in endocrinology and metabolism, 2012-08, Vol.23 (8), p.365-371

2012

Volltextzugriff (PDF)

Metabolic and molecular responses to leucine‐enriched branched chain amino acid supplementation in the skeletal muscle of alcoholic cirrhosis

Hepatology (Baltimore, Md.), 2015-06, Vol.61 (6), p.2018-2029

2015

Volltextzugriff (PDF)

Patients with Nonalcoholic Fatty Liver Disease Have a Low Response Rate to Vitamin D Supplementation

The Journal of nutrition, 2017-10, Vol.147 (10), p.1938-1946

2017

Volltextzugriff (PDF)

Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease

Journal of hepatology, 2011-04, Vol.54 (4), p.753-759

2011

Volltextzugriff (PDF)

Continued muscle loss increases mortality in cirrhosis: Impact of aetiology of liver disease

Liver international, 2020-05, Vol.40 (5), p.1178-1188

2020

Volltextzugriff (PDF)

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

The Lancet (British edition), 2015-03, Vol.385 (9972), p.956-965

2015

Volltextzugriff (PDF)

1 – 25 von 626

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(553)
Mit Volltextzugriff
(529)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(626)
Japanisch
(81)

Erscheinungsjahr

n.n

Thema

Science & Technology
(301)
Life Sciences & Biomedicine
(294)
Humans
(260)
Gastroenterology & Hepatology
(186)
Male
(175)
Female
(162)
Middle Aged
(128)
Adult
(114)
Biological And Medical Sciences
(109)
Medical Sciences
(99)
Hepatology
(75)
Risk Factors
(64)
Gastroenterology. Liver. Pancreas. Abdomen
(58)
Liver Diseases
(55)
Gastroenterology And Hepatology
(54)
Non-Alcoholic Fatty Liver Disease
(52)
Biopsy
(49)
Aged
(47)
Liver. Biliary Tract. Portal Circulation. Exocrine Pancreas
(46)
Liver - Pathology
(45)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

The Natural History of Nonalcoholic Fatty Liver Disease—An Evolving View

Effect of Alcohol Consumption on Survival in Nonalcoholic Fatty Liver Disease: A National Prospective Cohort Study

Sarcopenia in Alcoholic Liver Disease: Clinical and Molecular Advances

Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: Findings and recommendations from an American Association for the Study of Liver Diseases–U.S. Food and Drug Administration Joint Workshop

Double-blind Randomized Placebo-controlled Clinical Trial of Omega 3 Fatty Acids for the Treatment of Diabetic Patients With Nonalcoholic Steatohepatitis

Nonalcoholic Steatohepatitis Decompensation and Portal Pressures

Pathophysiology of Nonalcoholic Steatohepatitis

Natural History of Nonalcoholic Fatty Liver Disease

Accuracy of ultrasonographic fatty liver index using point-of-care ultrasound in stratifying non-alcoholic fatty liver disease patients

Insulin resistance : A metabolic pathway to chronic liver disease

Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study

Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis

Late evening snack: Exploiting a period of anabolic opportunity in cirrhosis

Epidemiology of the metabolic syndrome in the USA

The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease

Accuracy of steatosis and fibrosis NAFLD scores in relation to vibration controlled transient elastography: An NHANES analysis

Cytokeratin-18 Fragment Levels as Noninvasive Biomarkers for Nonalcoholic Steatohepatitis: A Multicenter Validation Study

Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: Present and future

Plasma metabolomic profile in nonalcoholic fatty liver disease

Role of ceramides in nonalcoholic fatty liver disease

Metabolic and molecular responses to leucine‐enriched branched chain amino acid supplementation in the skeletal muscle of alcoholic cirrhosis

Patients with Nonalcoholic Fatty Liver Disease Have a Low Response Rate to Vitamin D Supplementation

Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease

Continued muscle loss increases mortality in cirrhosis: Impact of aetiology of liver disease

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

Suchergebnisse filtern